A detailed history of Glen Eagle Advisors, LLC transactions in Haleon PLC stock. As of the latest transaction made, Glen Eagle Advisors, LLC holds 1,747 shares of HLN stock, worth $18,029. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,747
Holding current value
$18,029
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$8.01 - $8.64 $784 - $846
-98 Reduced 5.31%
1,747 $14.4 Million
Q1 2024

Jul 03, 2024

BUY
$8.02 - $8.67 $14,796 - $15,996
1,845 New
1,845 $15.7 Million
Q4 2023

Aug 13, 2024

BUY
$7.78 - $8.62 $7 - $8
1 Added 0.06%
1,745 $14.4 Million
Q3 2023

Aug 13, 2024

SELL
$7.85 - $8.94 $7 - $8
-1 Reduced 0.06%
1,744 $14.5 Million
Q2 2023

Aug 13, 2024

SELL
$8.04 - $9.0 $8 - $9
-1 Reduced 0.06%
1,745 $14.6 Million
Q3 2022

Aug 13, 2024

SELL
$5.63 - $7.49 $557 - $741
-99 Reduced 5.37%
1,746 $10.6 Million

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $47.7B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Glen Eagle Advisors, LLC Portfolio

Follow Glen Eagle Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glen Eagle Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Glen Eagle Advisors, LLC with notifications on news.